Report Back from SABCS 2021: What’s the Latest in MBC Research?
Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife

Report Back from SABCS 2021: What’s the Latest in MBC Research?

Learn about the most recent information released at the annual San Antonio Breast Cancer Symposium regarding metastatic breast cancer research with Dr. Peter Schmid, Professor of Cancer Medicine at Barts Cancer Institute in London, England. Dr. Schmid will provide a comprehensive update and answer your questions about these new developments.

Read More
Road to a Cure - ADC & SARM
Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife

Road to a Cure - ADC & SARM

How famous is Dr Hope Rugo? She belongs to a tiny elite group of oncologists who have their own Wikipedia page. Dr. Dennis Slamon is quite possibly the only other member. Enough said. No surprise that we can’t wait to hear what she has to say about a new class of drugs, known as ADCs and specifically, the first ADC for mTNBC that already has a nickname – Sassy (sacituzumab govitecan). Do you know what a SARM is? It is a special class of drugs for those who are Androgen Receptor (AR) positive. Listen and find out.

Read More
Road to a Cure - use of immunotherapy
Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife

Road to a Cure - use of immunotherapy

This week we are visiting Dr Stephanie Goff at the NIH in Bethesda, Maryland. Dr Goff is a surgical oncologist and a senior member of a research team led by Dr. Steven A. Rosenberg, a man widely regarded as the father of immunotherapy. A friend, who knows a thing or two about this place. is joining us on this trip. Her name is Judy Perkins, and she is the first MBC patient who has been cured by a revolutionary immunotherapy treatment, known as adoptive cell therapy, that was administered by Dr Goff and her colleagues at the NCI.

Read More
A conversation with Judy Perkins
MBC Patients, Patient Advocates, Living with MBC, MBC Stories, Immunotherapy, Diagnosis and Treatment, Making Our Best MBC Life, Essential Knowledge Our MBClife MBC Patients, Patient Advocates, Living with MBC, MBC Stories, Immunotherapy, Diagnosis and Treatment, Making Our Best MBC Life, Essential Knowledge Our MBClife

A conversation with Judy Perkins

Judy Perkins joins co-host Victoria Goldberg to share her incredible story. She is a unicorn and a clinical trial success. Judy tells the whole story - the good, the bad, the joyful, the difficult, the grief, the friendship. And when asked is MBC chronic - well we don’t bleep out her reaction.

Read More